Glenmark Pharma gets USFDA nod for seizure treatment drug
Posted by
www.biotecnika.org
Glenmark Pharmaceuticals Ltd has received final approval from the
United States Food and Drug Administration (USFDA) for Topiramate
extended-release capsules USP in the strengths of 25 mg, 50 mg, 100
mg, 150 mg, and 200 mg, Glenmark said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-seizure-treatment-drug/articleshow/80662988.cms
Subscribe to:
Post Comments (Atom)
Post a Comment